DK0729352T3 - Interdigiteringsfusionsliposomer indeholdende arachidonsyremetabolitter - Google Patents

Interdigiteringsfusionsliposomer indeholdende arachidonsyremetabolitter

Info

Publication number
DK0729352T3
DK0729352T3 DK95901236T DK95901236T DK0729352T3 DK 0729352 T3 DK0729352 T3 DK 0729352T3 DK 95901236 T DK95901236 T DK 95901236T DK 95901236 T DK95901236 T DK 95901236T DK 0729352 T3 DK0729352 T3 DK 0729352T3
Authority
DK
Denmark
Prior art keywords
arachidonic acid
acid metabolites
liposomes containing
interdigitation
containing arachidonic
Prior art date
Application number
DK95901236T
Other languages
English (en)
Inventor
Andrew S Janoff
Sharma R Minchey
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Application granted granted Critical
Publication of DK0729352T3 publication Critical patent/DK0729352T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
DK95901236T 1993-11-16 1994-11-15 Interdigiteringsfusionsliposomer indeholdende arachidonsyremetabolitter DK0729352T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15317693A 1993-11-16 1993-11-16
PCT/US1994/013063 WO1995013797A1 (en) 1993-11-16 1994-11-15 Interdigitation-fusion liposomes containing arachidonic acid metabolites

Publications (1)

Publication Number Publication Date
DK0729352T3 true DK0729352T3 (da) 1999-09-20

Family

ID=22546097

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95901236T DK0729352T3 (da) 1993-11-16 1994-11-15 Interdigiteringsfusionsliposomer indeholdende arachidonsyremetabolitter

Country Status (13)

Country Link
EP (1) EP0729352B1 (da)
JP (1) JP3798016B2 (da)
KR (1) KR960705546A (da)
AT (1) ATE176397T1 (da)
AU (1) AU681469B2 (da)
CA (1) CA2175350A1 (da)
DE (1) DE69416425T2 (da)
DK (1) DK0729352T3 (da)
ES (1) ES2126868T3 (da)
FI (1) FI962080A (da)
GR (1) GR3030123T3 (da)
NO (1) NO312808B1 (da)
WO (1) WO1995013797A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003342196A (ja) * 2002-05-31 2003-12-03 Mukku:Kk 静脈注射用組成物、その製造法およびその製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU617678B2 (en) * 1987-05-22 1991-12-05 Liposome Company, Inc., The Prostaglandin-lipid formulations
US5262168A (en) * 1987-05-22 1993-11-16 The Liposome Company, Inc. Prostaglandin-lipid formulations
PT96465B (pt) * 1990-01-12 1998-06-30 Liposome Co Inc Liposomas e geles obtidos por fusao interdigital e processo para a sua obtencao
ES2128343T3 (es) * 1991-05-07 1999-05-16 Liposome Co Inc Formulaciones de prostaglandina liposomica.
JPH05139977A (ja) * 1991-05-17 1993-06-08 Green Cross Corp:The プロスタグランジン類リポソーム複合体を充填した注射器

Also Published As

Publication number Publication date
WO1995013797A1 (en) 1995-05-26
DE69416425D1 (de) 1999-03-18
FI962080A0 (fi) 1996-05-15
AU1055595A (en) 1995-06-06
GR3030123T3 (en) 1999-07-30
ATE176397T1 (de) 1999-02-15
EP0729352A1 (en) 1996-09-04
FI962080A (fi) 1996-05-15
DE69416425T2 (de) 1999-06-10
CA2175350A1 (en) 1995-05-26
NO961949D0 (no) 1996-05-13
JP3798016B2 (ja) 2006-07-19
AU681469B2 (en) 1997-08-28
ES2126868T3 (es) 1999-04-01
EP0729352B1 (en) 1999-02-03
NO961949L (no) 1996-05-13
KR960705546A (ko) 1996-11-08
NO312808B1 (no) 2002-07-08
JPH09505302A (ja) 1997-05-27

Similar Documents

Publication Publication Date Title
DK0726764T3 (da) Multilamel-liposomale arachidonsyremetabolitformuleringer
HN1997000091A (es) Estacion de cebo para termitas.
DK0800503T3 (da) Hidtil ukendte trien-retinoidforbindelser og fremgangsmåder
DE69633293D1 (de) Für das Auge unschädliche Übertragung gefährlicher Laserstrahlen
ES2174293T3 (es) Microesferas farmaceuticas de acido valproico para la administracion oral.
DE69416425D1 (de) Arachidonsäuremetaboliten enthaltende interdigitations-fusions-liposomen
ES2158094T3 (es) Sales de adicion de acido de compuestos de 2,3,4,5-tetrahidro-1h-3-benzazepina.
ES2141978T3 (es) Retinoides triciclicos, metodos para su produccion y uso.
DE69722178T2 (de) Therapeutischer wirkstoff für augenerkrankungen
AU4505499A (en) Use of at least one acid from the citric acid cycle combined with glycerine as a pesticide
ES2022696B3 (es) Dispositivo de ensamblaje de dos caballetes entre si, al nivel de la viga maestra, para la realizacion de armazones y estructuras.
FR2547502B1 (fr) Matrice pour la diffusion continue et progressive d'un principe actif par voie transcutanee
IT1265422B1 (it) Unguento farmaceutico privo di azione irritativa della pelle e procedimento per la sua preparazione
ES2105973B1 (es) Composicion liposomal para la regeneracion celular de la piel.
ES1037555Y (es) Expositor autonomo para la venta combinada de laminas y de marcos.
SE8207186D0 (sv) Terapeutiskt aktiva, membranstabiliserande medel
ITBO950563A0 (it) Sistema per la sostituzione di accumulatori elettrici.
GEU1998372Y (en) Medicinal Ointment “Tsimeriali” for Paradontitis
ES1030257Y (es) Dispositivo para la emision de mensajes publicitarios perfecionado.